- According to estimates from 13 analysts, Hims & Hers Health, Inc. stock's average price target has fallen from $30.69 to $30.15, with forecasts ranging from $21 to $40 per share
- Based on the Jul. 28 closing price, the updated target implies approximately 3% potential upside
- Consensus rating remains at “Hold” across 18 covering analysts, with 4 Buys, 12 Holds and 2 Sells
Explore more price target data and ratings for Hims & Hers Health, Inc. on the , and track all previous and future analyst recommendations for Hims & Hers Health, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.